Diana Mejía

Diana Mejía, MSc, currently serves as the VP and Group Director of Medical Strategy at Grey, a position held since 2021, after serving as the Director of Medical Strategy and Medical Strategist. Prior experience includes roles as Senior Medical Writer at TANK Worldwide, Medical Writer at IC Axon, and Drug Safety Specialist and Pharmacovigilance Lead at Merck. Diana has also contributed as the Editorial Team Chief at The Bogota Post and as an Official Translator and Interpreter for the Colombian Ministry of Foreign Affairs. Educational credentials include a Master of Science in Pharmacology and Therapeutics from McGill University, a Bachelor of Science in Biochemistry also from McGill University, a Certificate in Healthcare Marketing and Communications from New York University, and a Certificate in Professional Translation from Universidad Nacional de Colombia.